A partnership between ATP and pharmaceutical company GlaxoSmithKline began on the eve of the 2005 Australian Open in Melbourne to address concerns over supplements used by professional tennis players.
Subscribe to unlock this article
Explore our subscription options to continue reading our industry-leading content!
Already have an account? Sign in here